Skip
UTPhysicians logoUT Physicians - a part of UTHealth

888-4UT-DOCS | 888-488-3627

  • About Us
    About UT Physicians Careers Contact Us News Health Programs/Services Patient Stories Videos
  • Find a Provider / Clinic
    Search By Specialty Search Providers Search By Name Search By Location
  • Patient Information
    About your Visit Billing Information Clinical Trials Insurance Refer a patient Make an Appointment International Patients Medical Records Legal Billing Records
  • Health Programs/Services
  • Make an Appointment
  • Pay My Bill
  • MyUTP Portal
  • Careers

UTHealth Research

Other Categories
  • Cardiothoracic & Vascular Surgery
  • Children's Health Stories
  • Coronavirus
  • Coronavirus Español
  • COVID-19 Patient Resources
  • Ear, Nose, and Throat Stories
  • Epilepsy
  • Featured
  • Heart Care
  • In the Media
  • In the Media Español
  • News
  • Orthopedics
  • Patient Stories
  • Pediatric Surgery
  • UTHealth COVID-19 Research
  • UTHealth Research
  • Women's Health Stories
  • 1
  • 2
  • 3
  • Next

UTHealth establishes John S. Dunn Behavioral Sciences Center to address gaps in mental health care

Photo of Scott Lane, PhD, and Joy Schmitz, PhD, of the Faillace Department of Psychiatry and Behavioral Sciences at UTHealth, are part of the Center for Neurobehavioral Research on Addiction.

The John S. Dunn Foundation has made a transformative $25 million commitment to The University of Texas Health Science Center at Houston (UTHealth) to bolster the university’s behavioral health initiatives and address significant gaps in mental health care services in our communities.

Read full article
  • UTHealth launches Many Faces. One Mission. campaign with transformational gift A photograph of a physician with an older couple and the words, at UTHealth, we have many stories to tell.

    The University of Texas Health Science Center at Houston (UTHealth) publicly launched its first comprehensive campaign Many Faces. One Mission. on Thursday, April 8. The campaign, representing the largest philanthropic effort in UTHealth’s history, aims to raise $500 million to address pressing health challenges and secure the institution’s future as a top health science center. Since the campaign’s quiet phase began in 2015, UTHealth’s closest friends have given more than $400 million in gifts and pledges.

  • Study finds why some cancer drugs may be ineffective Two scientists in a lab looking through microscope

    A possible explanation for why many cancer drugs that kill tumor cells in mouse models won’t work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and McGovern Medical School.

  • Novel study leverages health app and electronic health records from consented patients to track long-term effects of COVID-19 Female doctor uses tablet to show x-ray to senior man

    Researchers are using a novel health platform that links them to shared electronic health records from consented patients to track long-term effects of COVID-19 in a new study by UTHealth. 

  • Researchers find mobile stroke units improve outcomes and reduce disability among stroke patients Photo of the UTHealth mobile stroke unit. (Photo by UTHealth)

    Stroke patients received clot-busting medications such as tissue plasminogen activator (tPA) faster, more often, and recovered significantly better when treated via a mobile stroke unit (MSU) compared to standard management by Emergency Medical Services (EMS), according to researchers with The University of Texas Health Science Center at Houston (UTHealth) and Memorial Hermann-Texas Medical Center (TMC).

  • Researchers propose early stroke sign and symptom recognition tool for Spanish-speakers Patient in a medical consult wearing face mask

    Researchers with The University of Texas Health Science Center at Houston (UTHealth) have created an acronym, RAPIDO™, to move forward much-needed efforts to address stroke sign and symptom awareness among at-risk Spanish-speaking individuals.

  • Research shows a reduction in brain injury after stroke patients were given their own stem cells Stem Cell

    Treating patients with stem cells from their own bone marrow could lead to a reduction in brain injury after a stroke caused by a blood clot, according to research by The University of Texas Health Science Center at Houston (UTHealth).

  • Heart month: Researchers create Texas’ first statewide cardiac arrest registry, highlight racial disparities in CPR training Photo of Salil Bhandari, MD, demonstrating how to do bystander CPR safely during the COVID-19 pandemic. (Photo by UTHealth)

    Projections from Texas’ first cardiac arrest registry show that every day at least 60 Texans will suffer an out-of-hospital cardiac arrest, which is a sudden loss of heart function, breathing, and consciousness. If bystander cardiopulmonary resuscitation (CPR) is performed, the victim’s chance of survival can triple, but less than half of victims in the Lone Star State receive any bystander CPR, according to data from the registry.

  • Researchers identity characteristics of highest utilizers for mental health hospital services Photo of Jane Hamilton, PhD, investigates characteristics of high utilizers for mental health hospital services. (Photo credit: Cody Duty/UTHealth)

    Dropping out of high school, having schizophrenia, or being diagnosed with a co-occurring personality disorder increases the likelihood of someone becoming a “high utilizer” of inpatient psychiatric hospital services, according to a new study by researchers at UTHealth. A high utilizer is someone who has been admitted three or more times within one year.

  • Researchers investigate whether stem cell therapy is a safe and effective for treatment-resistant bipolar disease Fabio Triolo, PhD, (from left); Matteo Costantini; and Deepa Bhattarai, MS, manufacturer mesenchymal cells in the Judith R. Hoffberger Cellular Therapeutics Laboratory. (Photo by UTHealth)

    A clinical trial to assess the safety and efficacy of stem cell therapy for treatment-resistant bipolar depression launched recently at The University of Texas Health Science Center at Houston (UTHealth).

  • New grant will allow researchers to house COVID-19 data Covid19 Data Research

    A $4 million subcontract grant for scientists to collect COVID-19 data from virus researchers across the country in order to develop a data coordinating center has been awarded to researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics.

  • Modified pain management strategy reduces opioid exposure to trauma patients, study shows Photo of John Harvin, MD, who led a team of physician-researchers to identify an opioid-minimizing pain management strategy for patients with acute trauma. (Photo credit: Cody Duty/UTHealth)

    A pain management regimen comprised mostly of over-the-counter medication reduced opioid exposure in trauma patients while achieving equal levels of pain control, according to a new study by physician-researchers at The University of Texas Health Science Center at Houston (UTHealth).

  • New antibody therapies found to potentially fight COVID-19 Researchers have discovered a potential new antibody therapy for COVID-19. (Photo by UTHealth)

    Researchers at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas Medical Branch at Galveston (UTMB Health) have discovered a potential new antibody therapy for COVID-19. The study was published in Nature Communications.

  • Researchers discover lack of a protein could be the key to Alzheimer’s disease New research shows a lack of a protein in the brain that keeps our tissues healthy as we age is linked to Alzheimer’s disease. (Photo by Getty Images)

    A lack of a protein in the brain that keeps our tissues healthy as we age is linked to Alzheimer’s disease, according to recent research from The University of Texas Health Science Center at Houston (UTHealth).

  • Researchers receive DOD funding to expand study of investigational drug to prevent ARDS in COVID-19 patients Photo of Ben Bobrow, MD, and Holger Eltzschig, MD, PhD, using the hypoxia chamber, which helped them discover that HIF activators could potentially treat damaged lungs. (Photo credit: Cody Duty/UTHealth)

    Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress syndrome (ARDS) in COVID-19 patients were awarded $5.1 million in funding from the U.S. Department of Defense (DOD) to expand the Phase II clinical trial at UTHealth. 

  • Gene pathway linked to schizophrenia identified through stem cell engineering Image of neurons derived from induced pluripotent stem cells from a schizophrenia patient. (Photo by Laura Stertz, PhD/UTHealth)

    Using human-induced pluripotent stem cells engineered from a single family’s blood samples, a gene signaling pathway linked to a higher risk for developing schizophrenia was discovered by scientists at UTHealth. The research was published in a recent issue of Neuropsychopharmacology.

  • Aging, diet-induced obesity, and metabolic disease link explored in new research Photograph of researcher Mikhail Kolonin, PhD, who led a study showing a link among aging, obesity, and metabolic disease. Photo credit is UTHealth.

    Unraveling the links among obesity, aging, telomere lengths and metabolic diseases is the subject of the study published today in Nature Metabolism by a collaborative research team at The University of Texas Health Science Center at Houston (UTHealth).

  • Researchers discover brain pattern that could improve mental health disorder diagnosis and treatment Foods for Improving Mental Health and Wellness

    A pattern in how the brain breaks down tryptophan, a common amino acid consumed through food, was discovered by researchers at UTHealth. The finding, which could help physicians more accurately diagnose and treat several major mental health disorders, was recently published in Molecular Psychiatry.

  • Researchers assess regenerative patch for in utero minimally invasive surgery for spina bifida defect Photo of KuoJen Tsao, MD; Ramesha Papanna, MD, MPH; Stephen Fletcher, MD; and Clifton Brock, MD, practicing the fetoscopic surgery. (Photo credit: Ramesha Papanna, MD, MPH)

    Researchers are investigating whether a human umbilical cord patch placed on the spina bifida defect could improve healing after minimally invasive fetoscopic surgery in a clinical trial at The University of Texas Health Science Center at Houston (UTHealth).

  • Linking medically complex children’s outpatient team with hospitalists improved inpatient care Photo of Dr, Ricardo Mosquera assisting a child as she does a breathing test for a story about clinical providers linking with hospitalists. Photo by Dwight Andrews.

    When medically complex children are hospitalized, linking hospitalists to their regular outpatient providers through an inpatient consultation service were more likely to improve outcomes, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).

  • Research unlocks new information about reading through visual dictionary in the brain Photo of Nitin Tandon, MD, who identified a crucial region in the temporal lobe which appears to act as the brain’s visual dictionary. (Photo by James LaCombe)

    The uniquely human ability to read is the cornerstone of modern civilization, yet very little is understood about the effortless ability to derive meaning from written words. Scientists at UTHealth have now identified a crucial region in the temporal lobe, know as the mid-fusiform cortex, which appears to act as the brain’s visual dictionary.

  • Patient with aortic aneurysm benefits from innovative, minimally invasive procedure Gustavo Oderich, MD, FACS, checks Rodolfo Sandoval’s heartbeat at his six-week post operation checkup. Oderich repaired Sandoval’s complex aortic aneurysm with a minimally invasive procedure. (Photo by: Caliann Ferguson/UTHealth)

    When Rodolfo Sandoval was told he would need to undergo open surgery to repair his thoracic and abdominal aortic aneurysm, he hesitated. At 73 years old, he was worried about the recovery process for a major, invasive procedure. Then COVID-19 arrived and he made the decision that he would only consider the surgery if it became a life or death situation.

  • Physicians investigate whether magnetic seizure therapy can treat bipolar depression Photo of Salih Selek, MD, who conducted magnetic seizure therapy (MST) in a clinical trial investigating whether the therapy can help relieve treatment-resistant depression in bipolar patients. (Photo by Maricruz Kwon/UTHealth)

    Researchers are assessing whether magnetic seizure therapy (MST) can help relieve treatment-resistant depression in bipolar patients in a clinical trial led by UTHealth. 

  • Neurologists test novel compound for lung and brain injury in severe COVID-19 patients Photo of how the investigational compound is designed to selectively attack the immune cells responsible for hyperinflammation, lung injury, and multi-organ failure caused by infections. (Photo credit: W20)

    Neurologists are researching whether a novel immunomodulatory treatment, OP-101, can dampen lung and brain injury in hospitalized COVID-19 patients through a clinical trial at The University of Texas Health Science Center at Houston (UTHealth).

  • Providing a safe environment for psychiatric patients during pandemic Photo of Doctor Lokesh Shahani and nurse Roshan Cherian wearing PPE to work in a special COVID-19 unit  at UTHealth Harris County Psychiatric Center. Photo by UTHealth.

    The very heart of inpatient care for psychiatric patients is socialization, group therapy, shared meals, and a standard two people per room. Then COVID-19 hit with the accompanying public health warnings to isolate, socially distance, and wear masks. UTHealth HCPC had to walk the line between the two.

  • Researchers seeking volunteers for COVID-19 vaccine study Carmel B. Dyer, MD, speaks to two trial participants at the UTHealth Clinical Research Unit at Memorial Hermann-Texas Medical Center. (Photo by: Roger Castro/UTHealth)

    A Phase III clinical trial to assess if a potential vaccine is effective at preventing symptomatic COVID-19 is now open for enrollment by The University of Texas Health Science Center at Houston (UTHealth) in collaboration with Memorial Hermann-Texas Medical Center.

  • 1
  • 2
  • 3
  • Next
UT Physicians A part of UTHealth

UT Professional Building
6410 Fannin Street | Houston, Texas 77030
888-4UT-DOCS (888-488-3627)

UT Physicians - facebook UT Physicians - instagram UT Physicians - twitter UT Physicians - linkedin UT Physicians - youtube

UT PHYSICIANS APP NOW AVAILABLE FOR DOWNLOAD

Downlaod the UT Physicians App on the Apple Store
Downlaod the UT Physicians App on Google Play

AN OFFICIAL ORTHOPEDIC AND SPORTS MEDICINE PROVIDER FOR

Houston Dynamo Logo
Houston Dash Logo

THE CLINICAL PRACTICE OF

McGovern Medical School at UTHealth
Contact / Feedback | Report Error | Patient Privacy | Web File Viewing | Site Policies | Employee Links

Copyright © 2018 to Present – The University of Texas Health Science Center at Houston (UTHealth)